Further Evaluation of Thalidomide's Ability to Potentiate the Immune Response to HIV-Infected Patients

Summary

To determine if Thalidomide modulates the production of HIV-suppressor factors (MIP-1 alpha, MIP-1 beta, Rantes) and TH1 type cytokines (IL-12 and INF-gamma) in HIV-infected patients and alters viral load.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications